可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]曾繁典.血管紧张素转换酶抑制剂的临床药理研究进展. 中国临床药理学杂志1991; 7 (2) : 85.
[2]朱晓明, 蒋长盛.巯甲丙脯酸的副作用.新药与临床1985; 4 (1) : 52.
[3]张步明, 吴葆杰.巯甲丙脯酸的不良反应.山东医药1992; 32 (7) : 52.
[4]邓万俊. 血管紧张素转换酶抑制剂的不良反应.中国医院药学杂志1991; 11 (2) : 90.
[5]Giles TD, Katz R, Sullivan J,et al.Short-and Longacting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure.JACC 1989; 13 (6) : 1240.
[6]李文林, 张继红, 李建华.巯甲丙脯酸停药后突发心衰2例报告. 临床儿科杂志1992; 10 (5) :336.
[7] Davis JB.Chest pain after captopril.Br J Med 1988; 296 (6616) 16: 214.
[8]Daly P, Rouleau JL , Cousineau D, et al.Acute effects of captopril on the coronary circulation of patients with hypertension and angina. Am J Med 1984; 76 (5B) : 111.
[9]钱佰琦.巯甲丙脯酸不良反应184 例分析.中级医刊 1990; 25 (4) : 46.
[10]孟俊清.巯甲丙脯酸致严重心律失常1 例.中国实用内科杂志1993; 13 (2) : 103.
[11]Packer M , Lee WH.Provocation of hyper-and hypokalemic sudden death during treatment with and withdrawal of converting-enzyme inhibition in severe chronic congestive heart failure.A m J Cardiol 1986; 57 (2) : 347.
[12]Singer DR, Macyegor GA.Angioneurotic edema associated with two angiotensin converting enzyme inhibitors.Br J Med 1986; 293 (6556) :1243.